(Prototype team page) |
|||
Line 3: | Line 3: | ||
− | < | + | <style type="text/css"> |
− | + | table.tableizer-table { | |
− | + | font-size: 12px; | |
− | + | border: 1px solid #CCC; | |
− | </ | + | font-family: Arial, Helvetica, sans-serif; |
− | + | } | |
− | < | + | .tableizer-table td { |
− | < | + | padding: 4px; |
− | < | + | margin: 3px; |
− | < | + | border: 1px solid #CCC; |
− | < | + | } |
− | < | + | .tableizer-table th { |
− | < | + | background-color: #FFFFFF; |
− | </ | + | color: #FFF; |
− | + | font-weight: bold; | |
− | </ | + | } |
− | + | </style> | |
− | < | + | <table class="tableizer-table"> |
− | < | + | <thead><tr class="tableizer-firstrow"><th>Orignal </th><th>Simplified</th></tr></thead><tbody> |
− | < | + | <tr><td>ADH1 promoter( pADH1)</td><td>ADH</td></tr> |
− | + | <tr><td>GAL1 promoter (pGAL1)</td><td>GAL</td></tr> | |
− | < | + | <tr><td>CUP1 promoter (pCUP1)</td><td>CU</td></tr> |
− | < | + | <tr><td>Nano-lantern cAMP 1.6</td><td>NLc</td></tr> |
− | < | + | <tr><td>human adrenergic receptor beta 2 (ADRB2)</td><td>hAR</td></tr> |
− | < | + | <tr><td>yeast nucleotide binding alpha subunit (Gpa2) with 5 amino acids modification</td><td>Gpa2M</td></tr> |
− | < | + | <tr><td>Yeast TRP section marker</td><td>TRP</td></tr> |
− | </ | + | <tr><td>Yeast HIS section marker</td><td>HIS</td></tr> |
− | + | <tr><td>Yeast LEU section marker</td><td>LEU</td></tr> | |
− | </ | + | <tr><td>6 x His-tag</td><td>his</td></tr> |
+ | </tbody></table> | ||
</html> | </html> |
Revision as of 20:19, 19 October 2016
Orignal | Simplified |
---|---|
ADH1 promoter( pADH1) | ADH |
GAL1 promoter (pGAL1) | GAL |
CUP1 promoter (pCUP1) | CU |
Nano-lantern cAMP 1.6 | NLc |
human adrenergic receptor beta 2 (ADRB2) | hAR |
yeast nucleotide binding alpha subunit (Gpa2) with 5 amino acids modification | Gpa2M |
Yeast TRP section marker | TRP |
Yeast HIS section marker | HIS |
Yeast LEU section marker | LEU |
6 x His-tag | his |